Candel Therapeutics, Inc. CADL Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s shares (diluted)?
- Candel Therapeutics, Inc. (CADL) reported shares (diluted) of 62.4M in Q1 2026.
- How has Candel Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Candel Therapeutics, Inc.'s shares (diluted) increased by 13.9% year-over-year, from 54.8M to 62.4M.
- What is the long-term trend for Candel Therapeutics, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s shares (diluted) has grown at a 34.4% compound annual growth rate (CAGR), from 65.6M to 214.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.